Single Cell Omics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Size, Share & Trends, Drivers, Restraints, Opportunities, Manufacturer, Applications, And Segments

  • AMR-1063326
  • May 2021
  • Biotechnology
  • 151 Pages
The Single Cell Omics Market research report comprises of an overall in depth-analysis such as market drivers, opportunities, restraints, latest developments and trends, segmentation of the market, competitive analysis, global as well as regional analysis by showcasing how each of these factors can improve the further growth of the market on an overall perspective. The report also showcases the overall market value which includes the historic data (2018-2019) and forecast data (2020-2028) generated through the revenue (USD Mn)
 
Report Parameters Details of Parameter
Market Size xx Million
Based Year 2020
Forecast Period Covered 2020 – 2028
Units for value Revenue in USD million and CAGR from 2020 to 2028
Covered Segments Component, Types, Applications, End-Users, and more.
Companies Covered Thermo Fisher Scientific Inc., Qiagen N.V., Illumina, Inc., Bio-Rad Laboratories, Inc., 0x Genomics, Inc., Namocell Inc., Takara Bio, Inc., Cytiva (GE Healthcare Life Sciences), Agilent Technologies Inc., NanoString Technologies, Inc.
Region Covered North America, Europe, Asia Pacific, Latin America, Middle East and Africa

COVID-19 Coverage
With the beginning of the COVID-19 pandemic in early 2020, all major economies around the world enforced severe lockdown restrictions to curb the spread of the virus. Apart from a few sectors such as healthcare and related essential services, most of the industries suffered tremendously due to inability to function in a normal fashion. Moreover, even some of the essential sectors suffered due to delays caused by supply chain disruptions and other travel complexities. However, with massive vaccination drives in most of the developed economies, some of the economies across the world experienced economic recovery from 2021. The Single Cell Omics market is expected to gain momentum in such economies and probably recover some of the losses inflicted in the year 2020. With continued efforts towards curbing the virus in the developing economies, the Single Cell Omics market is expected to attain Pre COVID-19 levels by mid-2022.

Single Cell Omics Report’s Assessment
The research report is formulated such that it offers a deep understating on the market drivers that are assimilating the growth of the market, the market opportunities that are going to provide future growth factors for the market and the market restraints which showcase the reasons as to why the market can get hampered and dissimilated. All these factors are considered keeping in view the historic and forecast analysis which can enlighten the above mentioned factors.

Thereby at a glance a reader can understand all the factors and prospects of the Single Cell Omics market and how it can assimilate and dissimilate based on each of the factors and figures mentioned in the report

Single Cell Omics Market Competitive and Premeditated Analysis
In the Single Cell Omics report major factors such latest tactical developments, competitors, research and development, participation of each region in the market and the competition among them, the latest news regarding company acquisitions and product launch, revenue of the competitors as well as the key offerings they provide all these factors are mentioned in the report with reasons to justify and understand them in depth.

The readers and purchaser of the Single Cell Omics research report can gain a comprehensive understanding of the market competition, the revenue of each major players and their contribution towards the market, attractive proposition analysis is provided in the report which sub divides the segments with respect to the largest segment that has contributed to the market growth and the fastest growing segment based on the size of the market as well as its overall appeal.
 
Major Key Players for Global Single Cell Omics Market:
The Single Cell Omics market research report offers the company profile of major key players including progress trends, competitive landscape breakdown, and key in regions development status. Thermo Fisher Scientific Inc., Qiagen N.V., Illumina, Inc., Bio-Rad Laboratories, Inc., 0x Genomics, Inc., Namocell Inc., Takara Bio, Inc., Cytiva (GE Healthcare Life Sciences), Agilent Technologies Inc., NanoString Technologies, Inc.

The Single Cell Omics market report showcases vast potentials of growth and assimilation which is going to provide the industry numerous opportunities to grow and generate revenue by understanding the segments and which segment is a potential part to increase the disposable income in the present and upcoming years.

Single Cell Omics Market Segmentation Analysis:
Each of the segment is explained in brief along with the revenue it generates for the market based on the historic and forecast data by highlighting the largest segment and the fastest growing segment with reasons to justify it.

The Global segmentation of the Single Cell Omics market:
By Technology
Tubing PCR
qPCR
Microarray
Next Generation Sequencing
Others
Application
Genomic Variation
Subpopulation Characterization
Circulating Tumor Cells
Cell Differentiation
Others
End User
Academic Institutes
Biopharmaceutical Companies
Clinical Research Institutes


Regional Analysis of the Single Cell Omics market:
The Single Cell Omics market is dived based on different regions such as North America, Europe, Asia Pacific, Latin America and the Middle East and Africa. And the analysis of each region is provided by highlighting the largest contribution region, the fastest growing region and the factors that is keeping the market active in the other regions is also mentioned in depth. Each regional segment also comprises of the revenue each segment holds in a specific region with reasons to justify the values.

By Regions:
  • North America (U.S and Canada)
  • Europe (U.K., Germany and France)
  • Asia Pacific (China, India and Japan)
  • Latin America (Mexico and Brazil)
  • Middle East and Africa (GCC Countries and South Africa)
 


Major Factors Included and highlighted in the Single Cell Omics report are as follows:
  • The overall market value along with historic and future data analysis.
  • The Growth drivers, opportunities and restraints are mention in detail.
  • The size of the entire Single Cell Omics market on a global perspective.
  • The CAGR value of the overall market from 2020 to 2028.
  • COVID-19 impact on the Single Cell Omics market and how it is coping up with the situation.
  • Major competitors and their contribution towards the market.
  • The segmentation analysis is included which provides a clear picture of the market bifurcation.
  • Tables and graphs that can easily been understood at a glance
  • Latest trends and news related to the Single Cell Omics market is included in the report.
Key Analytical Areas:
The report aims to offer a complete solution to various businesses operating in the Single Cell Omics market in making strategic decisions based on credible information and actionable insights. Thereby, the report covers various aspects of your requirements such as industry overview, market dynamics, regional analysis and competitive landscape. The report aims to provide insights to businesses in the Single Cell Omics market for numerous purposes such as:

     1. Strategic Decision Making:
With the help of this report, key decision makers can quickly analyze and identify growth opportunities in terms of numerous segments across various geographical regions. Thereby, this report enables organizations to identify and make strategic investments in specific market segments in order to gain maximum return on investment.

     2. Actionable Insights:
The report offers a deep dive into how companies are leveraging market conditions to make the most in the Single Cell Omics market. Thereby, the report offers numerous actionable insights into the best practices and key success factors relevant in the Single Cell Omics market. Using the insights included in the report, businesses can make quick decisions to achieve success in business operations.

     3. Competitive Snapshot:
In addition, to detailed information on the companies operating in the Single Cell Omics market, the report also includes a competitive snapshot of all the companies covered in the report. Thereby, this offers a visual representation of how all the companies stand comparatively based on their competencies, geographic presence, market hold, years of operations, employee and financial strength, among others.

Manufacturers and Segments

  • Thermo Fisher Scientific Inc.
  • Qiagen N.V.
  • Illumina, Inc.
  • Bio-Rad Laboratories, Inc.
  • 0x Genomics, Inc.
  • Namocell Inc.
  • Takara Bio, Inc.
  • Cytiva (GE Healthcare Life Sciences)
  • Agilent Technologies Inc.
  • NanoString Technologies, Inc.
  • Tubing PCR
  • qPCR
  • Microarray
  • Next Generation Sequencing
  • Others
  • Academic Institutes
  • Biopharmaceutical Companies
  • Clinical Research Institutes

Have query on this report?

Make an Enquiry
1. Preface
     1.1. Report Scope and Description
     1.2. Research Methodology
          1.2.1. Phase I-Secondary Research
          1.2.2. Phase II-Primary Research
          1.2.3. Phase II-Expert Panel Review
          1.2.4. Assumptions
          1.2.5. Approach Adopted

2. Executive Summarysegment Form
     2.1. Global Single Cell Omics Market Snapshot
          2.1.1. Global Single Cell Omics Market By Technology,2019
               2.1.1.1.Tubing PCR
               2.1.1.2.qPCR
               2.1.1.3.Microarray
               2.1.1.4.Next Generation Sequencing
               2.1.1.5.Others
          2.1.2. Global Single Cell Omics Market By End User,2019
               2.1.2.1.Academic Institutes
               2.1.2.2.Biopharmaceutical Companies
               2.1.2.3.Clinical Research Institutes
          2.1.3. Global Single Cell Omics Market By End-use,2019
          2.1.4. Global Single Cell Omics Market By Geography,2019

3. Global Single Cell Omics Market Dynamics
     3.1. Market Overview
     3.2. Market Inclination Insights Analysis
     3.3. Drivers
     3.4. Challenges
     3.5. Future Prospects
     3.6. Impact Analysis of Drivers and Challenges During the Forecast Period, (2020-2028)

4. Global Single Cell Omics Market Size (US$), By Technology, 2018 – 2028 
     4.1. Overview
          4.1.1. Market Share Analysis By Technology, 2019 vs.2028
          4.1.2. Attractive Investment Proposition By Technology, 2020
     4.2. Global Single Cell Omics Market Size (US$), By Technology, 2018 – 2028

5. Global Single Cell Omics Market Size (US$), By End User, 2018 – 2028 
     5.1. Overview
          5.1.1. Market Share Analysis By End User, 2019 vs.2028
          5.1.2. Attractive Investment Proposition By End User, 2020
     5.2. Global Single Cell Omics Market Size (US$), By End User, 2018 – 2028

6. Global Single Cell Omics Market Size (US$), By End-use, 2018 – 2028 
     6.1. Overview
          6.1.1. Market Share Analysis By End-use, 2019 vs.2028
          6.1.2. Attractive Investment Proposition By End-use, 2020
     6.2. Global Single Cell Omics Market Size (US$), By End-use, 2018 – 2028

7. Global Single Cell Omics Market Size (US$), By Geography, 2018 – 2028
     7.1. Overview
          7.1.1. Market Share Analysis by Geography, 2019 vs. 2028
          7.1.2. Attractive Investment Proposition by Geography, 2020
     7.2. North America Single Cell Omics Market Analysis, 2018 – 2028 
          7.2.1. North America Single Cell Omics Market Size (US$), By Country, 2018 – 2028 
               7.2.1.1. U.S.
               7.2.1.2. Canada
          7.2.2. North America Single Cell Omics Market Size (US$), By Technology, 2018 – 2028
          7.2.3. North America Single Cell Omics Market Size (US$), By End User, 2018 – 2028
          7.2.4. North America Single Cell Omics Market Size (US$), By End-use, 2018 – 2028
     7.3. Europe Single Cell Omics Market Analysis, 2018 – 2028 
          7.3.1.  Europe Single Cell Omics Market Size (US$), By Country, 2018 – 2028 
               7.3.1.1. U.K.
               7.3.1.2. Germany
               7.3.1.3. France
               7.3.1.4. Rest of Europe
          7.3.2. Europe Single Cell Omics Market Size (US$), By Technology, 2018 – 2028
          7.3.3. Europe Single Cell Omics Market Size (US$), By End User, 2018 – 2028
          7.3.4. Europe Single Cell Omics Market Size (US$), By End-use, 2018 – 2028
     7.4. Asia Pacific Single Cell Omics Market Analysis , 2018 – 2028
          7.4.1.  Asia Pacific Single Cell Omics Market Size (US$), By Country, 2018 – 2028 
               7.4.1.1. China
               7.4.1.2. Japan
               7.4.1.3. India
               7.4.1.4. Rest of Asia Pacific
          7.4.2. Asia Pacific Single Cell Omics Market Size (US$), By Technology, 2018 – 2028
          7.4.3. Asia Pacific Single Cell Omics Market Size (US$), By End User, 2018 – 2028
          7.4.4. Asia Pacific Single Cell Omics Market Size (US$), By End-use, 2018 – 2028
     7.5. Latin America Single Cell Omics Market Analysis, 2018 – 2028 
          7.5.1.  Latin America Single Cell Omics Market Size (US$), By Country, 2018 – 2028 
               7.5.1.1. Brazil
               7.5.1.2. Mexico
               7.5.1.3. Rest of Latin America
          7.5.2. Latin America Single Cell Omics Market Size (US$), By Technology, 2018 – 2028
          7.5.3. Latin America Single Cell Omics Market Size (US$), By End User, 2018 – 2028
          7.5.4. Latin America Single Cell Omics Market Size (US$), By End-use, 2018 – 2028
     7.6. Middle East & Africa (MEA) Single Cell Omics Market Analysis, 2018 – 2028 
          7.6.1.  MEA Single Cell Omics Market Size (US$), By Region, 2018 – 2028 
               7.6.1.1. GCC Countries
               7.6.1.2. South Africa
               7.6.1.3. Rest of MEA
          7.6.2. MEA Single Cell Omics Market Size (US$), By Technology, 2018 – 2028
          7.6.3. MEA Single Cell Omics Market Size (US$), By End User, 2018 – 2028
          7.6.4. MEA Single Cell Omics Market Size (US$), By End-use, 2018 – 2028

8. Company Profiles
     8.1. Competitive Analysis 
     8.2. Market Positioning of Key Vendors 
     8.3. Key Strategies adopted by the Leading Players
     8.4. Key Single Cell Omics Providers
        8.4.1 Thermo Fisher Scientific Inc.
                8.4.1.1 Business Description
                8.4.1.2 Thermo Fisher Scientific Inc. Geographic Operations
                8.4.1.3 Thermo Fisher Scientific Inc. Financial Information
                8.4.1.4 Thermo Fisher Scientific Inc. Product Positions/Portfolio
                8.4.1.5 Thermo Fisher Scientific Inc. Key Developments
        8.4.2 Qiagen N.V.
                8.4.2.1 Business Description
                8.4.2.2 Qiagen N.V. Geographic Operations
                8.4.2.3 Qiagen N.V. Financial Information
                8.4.2.4 Qiagen N.V. Product Positions/Portfolio
                8.4.2.5 Qiagen N.V. Key Developments
        8.4.3 Illumina, Inc.
                8.4.3.1 Business Description
                8.4.3.2 Illumina, Inc. Geographic Operations
                8.4.3.3 Illumina, Inc. Financial Information
                8.4.3.4 Illumina, Inc. Product Positions/Portfolio
                8.4.3.5 Illumina, Inc. Key Developments
        8.4.4 Bio-Rad Laboratories, Inc.
                8.4.4.1 Business Description
                8.4.4.2 Bio-Rad Laboratories, Inc. Geographic Operations
                8.4.4.3 Bio-Rad Laboratories, Inc. Financial Information
                8.4.4.4 Bio-Rad Laboratories, Inc. Product Positions/Portfolio
                8.4.4.5 Bio-Rad Laboratories, Inc. Key Developments
        8.4.5 0x Genomics, Inc.
                8.4.5.1 Business Description
                8.4.5.2 0x Genomics, Inc. Geographic Operations
                8.4.5.3 0x Genomics, Inc. Financial Information
                8.4.5.4 0x Genomics, Inc. Product Positions/Portfolio
                8.4.5.5 0x Genomics, Inc. Key Developments
        8.4.6 Namocell Inc.
                8.4.6.1 Business Description
                8.4.6.2 Namocell Inc. Geographic Operations
                8.4.6.3 Namocell Inc. Financial Information
                8.4.6.4 Namocell Inc. Product Positions/Portfolio
                8.4.6.5 Namocell Inc. Key Developments
        8.4.7 Takara Bio, Inc.
                8.4.7.1 Business Description
                8.4.7.2 Takara Bio, Inc. Geographic Operations
                8.4.7.3 Takara Bio, Inc. Financial Information
                8.4.7.4 Takara Bio, Inc. Product Positions/Portfolio
                8.4.7.5 Takara Bio, Inc. Key Developments
        8.4.8 Cytiva (GE Healthcare Life Sciences)
                8.4.8.1 Business Description
                8.4.8.2 Cytiva (GE Healthcare Life Sciences) Geographic Operations
                8.4.8.3 Cytiva (GE Healthcare Life Sciences) Financial Information
                8.4.8.4 Cytiva (GE Healthcare Life Sciences) Product Positions/Portfolio
                8.4.8.5 Cytiva (GE Healthcare Life Sciences) Key Developments
        8.4.9 Agilent Technologies Inc.
                8.4.9.1 Business Description
                8.4.9.2 Agilent Technologies Inc. Geographic Operations
                8.4.9.3 Agilent Technologies Inc. Financial Information
                8.4.9.4 Agilent Technologies Inc. Product Positions/Portfolio
                8.4.9.5 Agilent Technologies Inc. Key Developments
        8.4.10 NanoString Technologies, Inc.
                8.4.10.1 Business Description
                8.4.10.2 NanoString Technologies, Inc. Geographic Operations
                8.4.10.3 NanoString Technologies, Inc. Financial Information
                8.4.10.4 NanoString Technologies, Inc. Product Positions/Portfolio
                8.4.10.5 NanoString Technologies, Inc. Key Developments

LIST OF TABLES

TABLE 1 Market Snapshot: Global Single Cell Omics Market 
TABLE 2 Impact Indicators 
TABLE 3 Impact Analysis of Drivers and Restraints 
TABLE 4 North America Single Cell Omics Market Revenue, By Technology, 2018 – 2028 (US$ Mn) 
TABLE 5 North America Single Cell Omics Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 6 North America Single Cell Omics Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 7 Europe Single Cell Omics Market Revenue, By Technology, 2018 – 2028 (US$ Mn) 
TABLE 8 Europe Single Cell Omics Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 9 Europe Single Cell Omics Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 10 Asia Pacific Single Cell Omics Market Revenue, By Technology, 2018 – 2028 (US$ Mn) 
TABLE 11 Asia Pacific Single Cell Omics Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 12 Asia Pacific Single Cell Omics Market Revenue, By End-use, 2018 – 2028 (US$ Mn) 
TABLE 13 Latin America Single Cell Omics Market Revenue, By Technology, 2018 – 2028 (US$ Mn) 
TABLE 14 Latin America Single Cell Omics Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 15 Latin America Single Cell Omics Market Revenue, By End-use, 2018 – 2028 (US$ Mn)
TABLE 16 MEA Single Cell Omics Market Revenue, By Technology, 2018 – 2028 (US$ Mn) 
TABLE 17 MEA Single Cell Omics Market Revenue, By End User, 2018 – 2028 (US$ Mn) 
TABLE 18 MEA Single Cell Omics Market Revenue, By End-use, 2018 – 2028 (US$ Mn)

LIST OF FIGURES

FIG. 1 Global Single Cell Omics: Market Segmentation 
FIG. 2 Global Single Cell Omics Market: Research Methodology 
FIG. 3 Top-Down and Bottom-up Approach 
FIG. 4 Global Single Cell Omics Market, By Technology, 2019 (US$ Mn) 
FIG. 5 Global Single Cell Omics Market, By End User, 2019 (US$ Mn) 
FIG. 6 Global Single Cell Omics Market, By End-use, 2019 (US$ Mn) 
FIG. 7 Global Single Cell Omics Market, By Geography, 2019 (US$ Mn) 
FIG. 8 Global Single Cell Omics Market Revenue and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG. 9 Attractive Investment Proposition 
FIG. 10 Market Positioning of Key Single Cell Omics Providers, 2019
FIG. 11 Global Single Cell Omics Market Revenue Contribution, By Technology, 2019 & 2028 (Value %) 
FIG. 12 Global Single Cell Omics Market Revenue Contribution, By End User, 2019 & 2028 (Value %) 
FIG. 13 Global Single Cell Omics Market Revenue Contribution, By End-use, 2019 & 2028 (Value %) 
FIG. 14 North America Single Cell Omics Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 15 Europe Single Cell Omics Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 16 Asia Pacific Single Cell Omics Market Revenue, 2018 – 2028, (US$ Mn) 
FIG. 17 Latin America Single Cell Omics Market Revenue, 2018 – 2028, (US$ Mn)
FIG. 18 MEA Single Cell Omics Market Revenue, 2018 – 2028, (US$ Mn)

Key Takeaways:

1. Market value and estimate of the Single Cell Omics market for the period from 2020 to 2028
2. Compounded annual growth rate (CAGR%) for individual segments in various regional markets for a period from 2020 to 2028
3. Value chain analysis
4. Market share study combined with competitive landscape of major players
5. Profiles of major market players covering overall business operations, geographic occurrence, product portfolio, financial status and news coverage 

List of Tables

TABLE  Market Snapshot: Global Single Cell Omics Market
TABLE  Impact Pointers
TABLE  Impact Analysis of Drivers and Restraints
TABLE  North America Single Cell Omics Market Value, By Segment1, 2018 – 2028
TABLE  North America Single Cell Omics Market Value, By Segment2, 2018 – 2028
TABLE  North America Single Cell Omics Market Value, By Country, 2018 – 2028
TABLE  Europe Single Cell Omics Market Value, By Segment1, 2018 – 2028
TABLE  Europe Single Cell Omics Market Value, By Segment2, 2018 – 2028
TABLE  Europe Single Cell Omics Market Value, By Country, 2018 – 2028
TABLE  Asia Pacific Single Cell Omics Market Value, By Segment1, 2018 – 2028
TABLE  Asia Pacific Single Cell Omics Market Value, By Segment2, 2018 – 2028
TABLE  Asia Pacific Single Cell Omics Market Value, By Country, 2018 – 2028
TABLE  Latin America Single Cell Omics Market Value, By Segment1, 2018 – 2028
TABLE  Latin America Single Cell Omics Market Value, By Segment2, 2018 – 2028
TABLE  Latin America Single Cell Omics Market Value, By Country, 2018 – 2028
TABLE  MEA Single Cell Omics Market Value, By Segment1, 2018 – 2028
TABLE  MEA Single Cell Omics Market Value, By Segment2, 2018 – 2028
TABLE  MEA Single Cell Omics Market Value, By Country, 2018 – 2028
TABLE  Thermo Fisher Scientific Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Qiagen N.V.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Illumina, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Bio-Rad Laboratories, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  0x Genomics, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Namocell Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Takara Bio, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Cytiva (GE Healthcare Life Sciences): Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  Agilent Technologies Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
TABLE  NanoString Technologies, Inc.: Company Snapshot (Company Details, Geographical Presence, Product Portfolio, Recent News and Announcements)
 

List of Figures

FIG.  Global Single Cell Omics Market: Research Methodology
FIG.  Top-Down and Bottom Up Approach
FIG.  Global Single Cell Omics Market, By Segment1, 2019 (US$ Mn)
FIG.  Global Single Cell Omics Market, By Segment2, 2019 (US$ Mn)
FIG.  Global Single Cell Omics Market, By Geography, 2019 (US$ Mn)
FIG.  Global Single Cell Omics Market Value and Growth, 2018 – 2028, (US$ Mn) (Y-o-Y %)
FIG.  Attractive Investment Proposition
FIG.  Market Positioning of Key Single Cell Omics Providers, 2016
FIG.  Global Single Cell Omics Market Value Share, By Segment1, 2019 & 2028 (% Value)
FIG.  Global qPCR Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Microarray Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Next Generation Sequencing Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Others Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Single Cell Omics Market Value Share, By Segment2, 2019 & 2028 (% Value)
FIG.  Global Biopharmaceutical Companies Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Clinical Research Institutes Market Value, 2018 – 2028, (US$ Mn)
FIG.  Global Market Value, 2018 – 2028, (US$ Mn)
FIG.  U.S. Single Cell Omics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Canada Single Cell Omics Market Value, 2018 – 2028, (US$ Mn)
FIG.  UK Single Cell Omics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Germany Single Cell Omics Market Value, 2018 – 2028, (US$ Mn)
FIG.  France Single Cell Omics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Europe Single Cell Omics Market Value, 2018 – 2028, (US$ Mn)
FIG.  China Single Cell Omics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Japan Single Cell Omics Market Value, 2018 – 2028, (US$ Mn)
FIG.  India Single Cell Omics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Asia Pacific Single Cell Omics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Mexico Single Cell Omics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Brazil Single Cell Omics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of Latin America Single Cell Omics Market Value, 2018 – 2028, (US$ Mn)
FIG.  GCC Countries Single Cell Omics Market Value, 2018 – 2028, (US$ Mn)
FIG.  South Africa Single Cell Omics Market Value, 2018 – 2028, (US$ Mn)
FIG.  Rest of MEA Single Cell Omics Market Value, 2018 – 2028, (US$ Mn)